Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15


Whole Genome Sequencing of 39 Invasive Streptococcus pneumoniae Sequence Type 199 Isolates Revealed Switches from Serotype 19A to 15B.

Makarewicz O, Lucas M, Brandt C, Herrmann L, Albersmeier A, Rückert C, Blom J, Goesmann A, van der Linden M, Kalinowski J, Pletz MW.

PLoS One. 2017 Jan 3;12(1):e0169370. doi: 10.1371/journal.pone.0169370. eCollection 2017.


Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection.

Zhang L, Li Z, Wan Z, Kilby A, Kilby JM, Jiang W.

Vaccine. 2015 Aug 26;33(36):4430-6. doi: 10.1016/j.vaccine.2015.06.077. Epub 2015 Jun 30. Review.


Molecular characterization and antimicrobial susceptibility of Streptococcus pneumoniae isolated from children hospitalized with respiratory infections in Suzhou, China.

Geng Q, Zhang T, Ding Y, Tao Y, Lin Y, Wang Y, Black S, Zhao G.

PLoS One. 2014 Apr 7;9(4):e93752. doi: 10.1371/journal.pone.0093752. eCollection 2014.


Trends in antibiotic treatment of acute otitis media and treatment failure in children, 2000-2011.

McGrath LJ, Becker-Dreps S, Pate V, Brookhart MA.

PLoS One. 2013 Dec 4;8(12):e81210. doi: 10.1371/journal.pone.0081210. eCollection 2013.


Endocarditis with ruptured sinus of Valsalva aneurysm caused by nonvaccine Streptococcus pneumoniae serotype 21.

Patra KP, Vanchiere JA, Bocchini JA Jr, Wu AC, Jackson RD, Kiel EA, Mello D.

Tex Heart Inst J. 2012;39(2):277-80.


Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean: a systematic review and meta-analysis, 1990-2010.

Castañeda E, Agudelo CI, De Antonio R, Rosselli D, Calderón C, Ortega-Barria E, Colindres RE.

BMC Infect Dis. 2012 May 28;12:124. doi: 10.1186/1471-2334-12-124. Review.


In vitro activity of ceftaroline against clinical isolates of Streptococcus pneumoniae recovered in 43 U.S. medical centers during 2010-2011.

Doern GV, Diekema DJ, Heilmann KP, Dohrn CL, Riahi F, Richter SS.

Antimicrob Agents Chemother. 2012 Jun;56(6):3406-8. doi: 10.1128/AAC.00582-12. Epub 2012 Apr 9.


Evaluation of ceftaroline activity versus ceftriaxone against clinical isolates of Streptococcus pneumoniae with various susceptibilities to cephalosporins in an in vitro pharmacokinetic/pharmacodynamic model.

Steed ME, Vidaillac C, Winterfield P, Biek D, Rybak MJ.

Antimicrob Agents Chemother. 2012 May;56(5):2691-5. doi: 10.1128/AAC.06185-11. Epub 2012 Feb 21.


The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance.

Ampofo K, Pavia AT, Chris S, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO, Byington CL.

Pediatr Infect Dis J. 2012 Mar;31(3):228-34. doi: 10.1097/INF.0b013e31823dcc72.


The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.

Cooper D, Yu X, Sidhu M, Nahm MH, Fernsten P, Jansen KU.

Vaccine. 2011 Sep 22;29(41):7207-11. doi: 10.1016/j.vaccine.2011.06.056. Epub 2011 Jul 18.


Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.

Willems RJ, Hanage WP, Bessen DE, Feil EJ.

FEMS Microbiol Rev. 2011 Sep;35(5):872-900. doi: 10.1111/j.1574-6976.2011.00284.x. Epub 2011 Jul 4. Review.


Serotype replacement in disease after pneumococcal vaccination.

Weinberger DM, Malley R, Lipsitch M.

Lancet. 2011 Dec 3;378(9807):1962-73. doi: 10.1016/S0140-6736(10)62225-8. Epub 2011 Apr 12. Review.


Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008.

Tarragó D, Aguilar L, García R, Gimenez MJ, Granizo JJ, Fenoll A.

Antimicrob Agents Chemother. 2011 May;55(5):2297-302. doi: 10.1128/AAC.01494-10. Epub 2011 Feb 22.


Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema.

Blaschke AJ, Heyrend C, Byington CL, Obando I, Vazquez-Barba I, Doby EH, Korgenski EK, Sheng X, Poritz MA, Daly JA, Mason EO, Pavia AT, Ampofo K.

Pediatr Infect Dis J. 2011 Apr;30(4):289-94. doi: 10.1097/INF.0b013e3182002d14.


Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice.

Oliveira ML, Miyaji EN, Ferreira DM, Moreno AT, Ferreira PC, Lima FA, Santos FL, Sakauchi MA, Takata CS, Higashi HG, Raw I, Kubrusly FS, Ho PL.

PLoS One. 2010 May 27;5(5):e10863. doi: 10.1371/journal.pone.0010863.

Supplemental Content

Support Center